Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention.

MLA

Laeeq, Tooba, et al. “Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention.” Cancers, vol. 16, no. 7, Apr. 2024, p. 1325. EBSCOhost, https://doi.org/10.3390/cancers16071325.

APA

Laeeq, T., Ahmed, M., Sattar, H., Zeeshan, M. H., & Ali, M. B. (2024). Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention. Cancers, 16(7), 1325. https://doi.org/10.3390/cancers16071325

Chicago

Laeeq, Tooba, Maheen Ahmed, Hina Sattar, Muhammad Hamayl Zeeshan, and Meher Binte Ali. 2024. “Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention.” Cancers 16 (7): 1325. doi:10.3390/cancers16071325.